← back to search

Huihai Zhong

Ministry of Education Science and Technology · MW
Area of research
Biomedical Engineering · Biomaterials
Research interest
Research interests include Nanoplatforms for cancer theranostics, Nanoparticle-Based Drug Delivery, Ultrasound and Hyperthermia Applications, and Nanocluster Synthesis and Applications.
h-index
16
citations
1,095
works
26
NIH funding
primary concept
email

Recent publications

γ-Glutamyl transpeptidase-activable nanoprobe crosses the blood-brain barrier for immuno-sonodynamic therapy of glioma
Nature Communications 2024cited by 33position: middledoi
Nanodrug Augmenting Antitumor Immunity for Enhanced TNBC Therapy via Pyroptosis and cGAS-STING Activation
Nano Letters 2023cited by 84position: firstdoi
Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis
Acta Biomaterialia 2023cited by 53position: middledoi
Metal-organic framework nanoparticles hitchhiking on T cells for protein delivery to boost anticancer immunotherapy
Nano Today 2023cited by 22position: middledoi
Surgical Tumor-Derived Photothermal Nanovaccine for Personalized Cancer Therapy and Prevention
Nano Letters 2022cited by 89position: middledoi
GSH‐Responsive Metal–Organic Framework for Intratumoral Release of NO and IDO Inhibitor to Enhance Antitumor Immunotherapy
Small 2022cited by 77position: middledoi
Nanodrug regulates lactic acid metabolism to reprogram the immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
Biomaterials Science 2022cited by 50position: middledoi
Multifunctional Nanodrug Mediates Synergistic Photodynamic Therapy and MDSCs‐Targeting Immunotherapy of Colon Cancer
Advanced Science 2021cited by 127position: middledoi
Redox Responsive Metal Organic Framework Nanoparticles Induces Ferroptosis for Cancer Therapy
Small 2020cited by 160position: middledoi
Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide
Journal of Controlled Release 2018cited by 69position: middledoi
Targeting death receptors for drug-resistant cancer therapy: Codelivery of pTRAIL and monensin using dual-targeting and stimuli-responsive self-assembling nanocomposites
Biomaterials 2017cited by 71position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xintao Shuai · Sun Yat-sen University9 papers (2020–2024)Minzhao Lin · Institute of Biophysics6 papers (2022–2024)Zecong Xiao · Sun Yat-sen University5 papers (2022–2023)Gengjia Chen · Sun Yat-sen University4 papers (2022–2024)Bo Li · Kunming University of Science and Technology4 papers (2022–2024)Jinsheng Huang · Sun Yat-sen University2 papers (2023–2024)Rongpu Liang · Sun Yat-sen University2 papers (2021–2023)Yong Wang · Qingdao University2 papers (2020–2021)Shengxin Huang · Sun Yat-sen University2 papers (2021–2023)Lihua Du · Sun Yat-sen University2 papers (2020–2022)Dongbing Ding · Sun Yat-sen University2 papers (2021–2023)Yongzhuo Huang · Fudan University2 papers (2017–2018)Haozhe He · Sun Yat-sen University2 papers (2020–2022)Yongcheng An · Beijing University of Chinese Medicine2 papers (2020–2022)Yujun Cai · Sun Yat-sen University2 papers (2022–2022)Shisong Han · Zhuhai People's Hospital1 papers (2022–2022)Yang He · University of Massachusetts Amherst1 papers (2018–2018)Xiaopeng Mo · Shanghai University1 papers (2018–2018)Bo Wei · Ministry of Education1 papers (2023–2023)Tuanbing Liu · Zhengzhou University1 papers (2018–2018)